(Q40526951)

21 September 2017

title

Neuroleptic malignant syndrome associated with ziprasidone in an adolescent (English)

1 reference

neuroleptic malignant syndrome

21 September 2017

1 reference

1 reference

Joseph Leibold

1

1 reference

21 September 2017

Vipul Patel

series ordinal

2

1 reference

21 September 2017

Rashed A Hasan

series ordinal

3

1 reference

21 September 2017

publication date

1 July 2004

1 reference

21 September 2017

published in

Clinical Therapeutics

1 reference

21 September 2017

volume

26

1 reference

21 September 2017

issue

7

1 reference

21 September 2017

page(s)

1105-1108

1 reference

Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990182-8

7 January 2021

Neuroleptic Malignant Syndrome with ziprasidone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990182-8

7 January 2021

Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990182-8

7 January 2021

Neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990182-8

7 January 2021

Neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990182-8

7 January 2021

10.1016/S0149-2918(04)90182-8

Identifiers

DOI

1 reference

21 September 2017

1 reference